Manning & Napier Advisors LLC decreased its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 20.4% during the second quarter, according to its most recent Form 13F filing with the SEC. The fund owned 40,653 shares of the medical equipment provider’s stock after selling 10,396 shares during the period. Manning & Napier Advisors LLC owned approximately 0.11% of Intuitive Surgical worth $38,024,000 as of its most recent SEC filing.
Other large investors have also added to or reduced their stakes in the company. Brown Advisory Securities LLC boosted its stake in Intuitive Surgical by 1.4% in the first quarter. Brown Advisory Securities LLC now owns 2,247 shares of the medical equipment provider’s stock valued at $1,722,000 after buying an additional 31 shares during the last quarter. Vident Investment Advisory LLC boosted its stake in Intuitive Surgical by 137.0% in the first quarter. Vident Investment Advisory LLC now owns 9,572 shares of the medical equipment provider’s stock valued at $7,337,000 after buying an additional 5,534 shares during the last quarter. Marshall Wace North America L.P. acquired a new stake in Intuitive Surgical during the first quarter valued at $9,596,000. Credit Suisse AG boosted its stake in Intuitive Surgical by 12.1% in the first quarter. Credit Suisse AG now owns 111,246 shares of the medical equipment provider’s stock valued at $85,268,000 after buying an additional 11,965 shares during the last quarter. Finally, Forte Capital LLC ADV boosted its stake in Intuitive Surgical by 10.6% in the first quarter. Forte Capital LLC ADV now owns 2,562 shares of the medical equipment provider’s stock valued at $1,964,000 after buying an additional 245 shares during the last quarter. Hedge funds and other institutional investors own 96.71% of the company’s stock.
Intuitive Surgical, Inc. (NASDAQ:ISRG) traded up 0.29% during trading on Tuesday, hitting $940.97. 271,529 shares of the company’s stock traded hands. The stock has a market cap of $34.96 billion, a P/E ratio of 45.02 and a beta of 0.39. Intuitive Surgical, Inc. has a 12 month low of $610.71 and a 12 month high of $974.66. The company’s 50 day moving average is $938.03 and its 200-day moving average is $819.43.
Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Thursday, July 20th. The medical equipment provider reported $5.95 earnings per share for the quarter, topping the consensus estimate of $5.79 by $0.16. The company had revenue of $756.20 million for the quarter, compared to the consensus estimate of $724.51 million. Intuitive Surgical had a net margin of 28.44% and a return on equity of 15.99%. Intuitive Surgical’s revenue was up 12.8% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $5.62 EPS. On average, analysts predict that Intuitive Surgical, Inc. will post $23.86 earnings per share for the current year.
A number of research analysts have recently commented on ISRG shares. Zacks Investment Research upgraded Intuitive Surgical from a “hold” rating to a “buy” rating and set a $911.00 price target for the company in a research note on Monday, April 24th. Wedbush increased their price target on Intuitive Surgical from $835.00 to $875.00 and gave the stock an “outperform” rating in a report on Monday, April 24th. Leerink Swann reiterated an “outperform” rating on shares of Intuitive Surgical in a report on Wednesday, July 5th. Barclays PLC increased their price target on Intuitive Surgical from $870.00 to $1,000.00 and gave the stock an “overweight” rating in a report on Friday, July 21st. They noted that the move was a valuation call. Finally, Morgan Stanley restated an “overweight” rating and issued a $1,070.00 target price (up from $950.00) on shares of Intuitive Surgical in a research note on Tuesday, July 25th. Seven investment analysts have rated the stock with a hold rating, twelve have assigned a buy rating and one has issued a strong buy rating to the stock. The stock has an average rating of “Buy” and a consensus target price of $980.03.
In related news, VP Jamie Samath sold 48 shares of the business’s stock in a transaction on Friday, May 5th. The shares were sold at an average price of $850.00, for a total value of $40,800.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, SVP Mark J. Meltzer sold 3,000 shares of the business’s stock in a transaction on Monday, June 12th. The shares were sold at an average price of $887.09, for a total transaction of $2,661,270.00. Following the completion of the transaction, the senior vice president now owns 3,046 shares of the company’s stock, valued at $2,702,076.14. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 34,113 shares of company stock valued at $31,699,890. Company insiders own 2.50% of the company’s stock.
About Intuitive Surgical
Intuitive Surgical, Inc (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.
Receive News & Ratings for Intuitive Surgical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.
